NCT05807490 - A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 5, 2023

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions

Healthy

Interventions

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every 12 hour (BID) over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions BID over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions daily (QD) over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every QD over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions QD over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions QD over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every 12 hour (BID) or everyday (QD) over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions every 12 hour (BID) or everyday (QD) over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions QD over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days

DRUG

PF-07328948

Single doses of PF-07328948 will be administered as oral suspension (single dose) and oral tablet (single dose) under fed and fasted condition

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions QD over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions QD over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days

DRUG

Placebo

Placebo will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days

DRUG

PF-07328948

PF-07328948 will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days

Trial Locations (2)

06511

New Haven Clinical Research Unit, New Haven

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels